420 filings
Page 15 of 21
8-K
otgczw
27 Mar 17
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2016 Financial Results
12:00am
S-8
io2xqp o008v6l
17 Jan 17
Registration of securities for employees
12:00am
8-K
pcf6xuac0dk
15 Dec 16
Departure of Directors or Certain Officers
12:00am
424B5
yrbmalefzb2xs1nkkae
5 Dec 16
Prospectus supplement for primary offering
12:00am
8-K
4fkf d4esu1pozs7
5 Dec 16
Other Events
12:00am
8-K
7qvygj3
5 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
ootrr9kqcwhrorgi
14 Nov 16
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Third Quarter 2016 Financial Results
12:00am
8-K
8wnrw1qp7no 1tg3
27 Sep 16
Onconova Announces Successful End-of-Phase 2 Meeting with FDA for Oral Rigosertib and Azacitidine Combination
12:00am
8-K
jg2rkc xculhd53kb
30 Aug 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
yto1py 1lj
15 Aug 16
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2016 Financial Results
12:00am
8-A12B
3iyga
27 Jul 16
Registration of securities on exchange
12:00am
424B3
5toge
22 Jul 16
Prospectus supplement
12:00am
8-K
b0uff3x43jv
13 Jul 16
Entry into a Material Definitive Agreement
12:00am
424B4
2yn84wfn8tvf3
8 Jul 16
Prospectus supplement with pricing info
12:00am
EFFECT
gdhtfdw24cemgxbr
7 Jul 16
Notice of effectiveness
12:00am
CORRESP
hz5ebdc8hu
5 Jul 16
Correspondence with SEC
12:00am